| Business Summary | | Provalis
PLC
is
an
integrated
healthcare
company
with
three
separate
divisions
focused
on
the
supply
and
sale
of
prescription
medicines,
the
development
and
global
sale
of
medical
diagnostics
and
the
development
of
new
therapeutic
products.
The
Healthcare
division
supplies,
sells
and
markets
branded
third
party
prescription
medicines
in
the
United
Kingdom
to
general
practitioners
and
hospitals.
Its
product
range
includes
products
for
use
in
the
medical
areas
of
gastroenterology,
osteoporosis,
migraine
and
dermatology.
The
Medical
Diagnostics
division
develops
and
sells
medical
diagnostic
products
to
world
markets
through
distributors.
The
division
has
launched
the
diagnostic
products
Glycosal
and
Osteosal,
in
the
areas
of
diabetes
and
osteoporosis
respectively,
and
also
has
a
worldwide
franchise
in
diagnostic
products
for
infectious
diseases.
The
Therapeutics
Research
&
Development
division
develops
new
therapeutic
products,
focusing
on
vaccine
candidates
for
infectious
diseases. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Provalis
Plc
is
an
integrated
healthcare
company
engaged
in
the
supply
and
sale
of
prescription
drugs
and
the
development
and
sale
of
medical
diagnostics
and
new
therapeutic
products.
For
the
six
months
ended
12/00,
revenues
rose
6%
to
L3.6
million.
Net
loss
fell
56%
to
L2.1
million.
Revenues
reflect
increased
sales
from
the
Medical
Diagnostics
segment
due
to
the
introduction
of
Glycosal.
Lower
loss
reflects
improved
operating
efficiencies
and
R&D
tax
credits. | More
from
Market Guide: Significant
Developments |
| Officers | | | More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|